NEPHA
Nepha Tıbbi Cihazlar is a Turkish medical device distributor founded in 1991 that exclusively represents eight global nuclear medicine brands, supplying hospitals and research institutions across Turkey with radiopharmaceutical generators, imaging devices, synthesis equipment, hot cells, and molecular imaging software.
- Company typePrivate
- Founded1991
- HeadquartersÇankaya
- Headcount11–50
- GTM typeB2B
- OfferingServices
What NEPHA does
Nepha Tıbbi Cihazlar A.Ş. (NEPHA) is a Turkish nuclear medicine medical device distribution and representation company founded in 1991 and headquartered in Ankara. Operating from three branch offices (Ankara, Istanbul, Izmir) and a nationwide dealer network, Nepha serves as the exclusive Turkish representative for eight international nuclear medicine brands: Curium (since 1992), ATT Scintomics (since 2009), Comecer, Crystal Photonics, Cyclomedica, Hermes Medical Solutions, Sirtex, and iThemba LABS.
The company's product portfolio spans the full nuclear medicine workflow, organized into diagnostic products (Mo-99/Tc-99m and Ge-68/Ga-68 isotope generators, Technescan cold kits for DTPA/HDP/MAG3/PYP imaging, I-131 therapeutic capsules), therapeutic products (Sirtex SIR-Spheres Y-90 resin microspheres for liver radioembolization), medical devices (Technegas Plus ventilation imaging system, Crystal Cam portable CZT gamma camera, Crystal Photonics gamma probes including straight, angled, laparoscopic, wireless and PET variants), synthesis equipment (GRP series modules and single-use cassettes for 68Ga, 177Lu, 18F and 11C radiopharmaceutical synthesis), shielded hot cells and isolators (Comecer MIP, BBS, BBST, Musa, Talia, Phaedra, Eliza, Elena, Manuela, PHL, Thecla series), dispensing systems (IRIS, Clio, Argo 2.0, Althea PC, Timo 2, Theodorico 2), dose calibrators (IBC, VDC-606), radiochemistry fume hoods, and the Hermia molecular imaging software platform. Underlying technical differentiators cited across products include scale reliability (Mo-99/Tc-99m generators), miniaturization (CZT-based Crystal Cam under 800g), GMP-compliant automated synthesis, and vendor-independent multimodal image fusion with DICOM integration.
Nepha generates revenue through hardware sales of specialized nuclear medicine equipment, recurring consumables (radiopharmaceutical generators and synthesis cassettes), and post-sale technical service. Pricing is not publicly disclosed and operates on a quote-based B2B model to hospital nuclear medicine departments, specialized nuclear medicine centers, and academic/research institutions across Turkey. The company cites 30+ years of experience, 150+ completed projects, and 500+ customers. Marketing is anchored in active participation in Turkish and European nuclear medicine congresses (UNTK, TGRD, EANM), satellite symposia, and a product-catalog website. The company holds a TSE Service Place Adequacy Certificate, a Turkish Atomic Energy Authority (TAEK) License, and distributes products certified to CE, GMP, MDR, ISO and registered in Turkey's ÜTS medical device tracking system.
NEPHA firmographics
Firmographics- Name
- NEPHA
- Legal name
- Nepha A.Ş.
- Website
- https://nepha.com.tr
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Nepha Tıbbi Cihazlar is a Turkish medical device distributor founded in 1991 that exclusively represents eight global nuclear medicine brands, supplying hospitals and research institutions across Turkey with radiopharmaceutical generators, imaging devices, synthesis equipment, hot cells, and molecular imaging software.
- Ownership category
- akta.pro rank
NEPHA industry classification
Industry- Product category
- Nuclear Medicine Medical Device Distribution
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Medical Equipment and Supplies Manufacturing (3391), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiopharmaceutical & Nuclear Medicine Distributors (HLAIAJAI)
Keywords
Where NEPHA is headquartered
LocationHeadquarters
- HQ city
- Çankaya
Offices3 records
Markets served
NEPHA business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Nuclear Medicine Medical Device Distribution: Nepha generates revenue primarily through the distribution and sale of nuclear medicine medical devices, radiopharmaceutical products, generators, and associated equipment. The company serves healthcare institutions across Turkey through direct sales offices and a dealer network, providing both product supply and post-sale technical service support.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
NEPHA product offering
Product offeringCore offering
NEPHA Tıbbi Cihazlar is a Turkish medical device distributor and exclusive representative office serving the nuclear medicine sector since 1991. The company distributes radiopharmaceutical generators (Mo-99/Tc-99m, Ge-68/Ga-68), therapeutic products (I-131 capsules, SIR-Spheres Y-90 microspheres), nuclear medicine equipment (hot cells, isolators, gamma probes, dose calibrators, dispensing systems, synthesis modules), and Hermia molecular imaging software on behalf of eight world-leading international manufacturers. NEPHA serves 500+ healthcare customers across Turkey through its Ankara, Istanbul, and Izmir offices backed by a nationwide dealer network, providing both product supply and post-sale technical service support.
Product overview
NEPHA Tıbbi Cihazlar is a medical device distributor and representative office in Turkey, serving the nuclear medicine sector since 1991. The company represents global leaders including Curium, Comecer, Crystal Photonics, ATT Scintomics (SCI-att), Cyclomedica, Hermes Medical Solutions, Sirtex, and iThemba LABS. The product portfolio encompasses: diagnostic products (Mo-99/Tc-99m and Ge-68/Ga-68 generators, Technescan cold kits for DTPA/HDP/MAG3/PYP imaging, Sodium Iodide I-131 capsules); therapeutic products (SIR-Spheres Y-90 resin microspheres for liver cancer); medical devices (Technegas Plus ventilation imaging system, Crystal Cam portable gamma camera, gamma probe systems including Crystal Probe Automatic, Straight Probe, Angled Probe, Laparoscopic Probe, and Wireless Gamma Probe, PET Probe); synthesis equipment (GRP synthesis modules and cassettes for PSMA, DOTATATE, FDG, FAPI tracers); hot cells and isolators (MIP, BBS, BBST, BBST Combo, Musa, Talia, Phaedra, Phaedra Combo, Eliza, Elena, Manuela, MIP LAF, PHL, Thecla series); dispensing systems (IRIS multidose injector, Clio, Argo 2.0, Althea PC, Timo 2, Theodorico 2 robotic dispenser); dose calibrators (IBC, VDC-606); fume hoods (FHR1-FHR3, FHR1 50, FHR1 50 LAF, FHR SSC, FHB10, BH Series); and software (Hermia molecular imaging platform). The offering integrates hardware, consumables, and software across the nuclear medicine workflow from radiopharmaceutical production to patient imaging and treatment.
Differentiator
Problem solved
Functional benefit
Products and services
- Ge-68/Ga-68 Generator (iThemba LABS) A radionuclide generator using Germanium-68 to produce Gallium-68 for PET imaging applications, particularly neuroendocrine tumor diagnostics. Provides reliable and efficient Gallium-68 production with 12-month usable lifetime.
- Mo-99/Tc-99m Generator (Curium) Chromatographic column-based generator producing sterile Sodium Pertechnetate (Tc-99m) for nuclear medicine imaging. Delivers Tc-99m daily with 6-hour half-life and 12-day usability window. Available in 5, 11, and 25 ml vial sizes with partial elution capability.
- Technegas Plus (Cyclomedica) Device for producing Technegas - carbon-coated Technetium-99m gas for lung ventilation scintigraphy. Used for diagnosing pulmonary embolism, COPD, asthma, and lung infections through nanoparticle-based gas inhalation. Requires only 4-5 breaths for procedure completion.
- Technescan Cold Kits Ready-to-use radiopharmaceutical kits including DTPA (kidney/lung), HDP (bone), MAG3 (kidney), and PYP (cardiac amyloidosis/red blood cell labeling) for SPECT imaging.
- Sodium Iodide I-131 Capsules Radioactive iodine capsule for thyroid disease treatment including hyperthyroidism (Graves', toxic multinodular goiter) and thyroid cancer therapy. Single-use with calibration range 37-7400 MBq.
- SIR-Spheres Y-90 Resin Microspheres (Sirtex) Yttrium-90 loaded resin microspheres for radioembolization treatment of liver tumors. Targeted radiation therapy delivering high-dose radiation directly to tumor cells while sparing healthy tissue.
- CrystalCam Hand-Held Gamma Camera (Crystal Photonics) Portable hand-held gamma camera with Cadmium Zinc Telluride (CZT) detector (40x40 mm² field of view, 2.46 mm pixel pitch, 256-pixel array) for pre-operative and intraoperative sentinel lymph node imaging, thyroid imaging, and ROLL/SNOLL procedures. Weighs under 800g, operates at 40-250 keV energy range.
- Crystal Probe Automatic (Crystal Photonics) State-of-the-art gamma probe system for rapid and accurate detection of radioactive isotopes during surgical procedures. Features automatic calibration and wireless probe options for sentinel lymph node biopsy and radioguided surgery.
- GRP Synthesis Modules (ATT Scintomics) GMP-compliant radiopharmaceutical synthesis modules (GRP-t, GRP 2V, smartGRP, GRP 3V, GRP 4V) for automated synthesis of PET tracers including PSMA, DOTATATE, FDG, and FAPI compounds. No metal contact during fully automatic synthesis.
- Synthesis Cassettes (ATT Scintomics) Single-use sterile cassettes containing all reagents and solvents for radiopharmaceutical synthesis. Compatible with various tracers including Ga-68, Lu-177, and F-18 compounds.
- Hermia Molecular Imaging Software (Hermes Medical Solutions) Vendor-independent molecular imaging software covering all clinical specialties including Oncology, Cardiology, Neurology, Dosimetry, and Theranostics & Treatment Planning. Features AI-powered automation, SUV calculation for all listed radionuclides, multimodal fusion of CT/PET/SPECT/MR, and automated segmentation.
- MIP Series Hot Cells (Comecer) Shielded cells designed to house automatic synthesis modules for radioisotope and radiopharmaceutical research. Feature negative pressure operation, AISI 316L stainless steel work chamber, modular design with 75/100 mm lead shielding, and 7-inch touch screen operator panel.
- IRIS Injection/Dispensing System (Comecer) Radiopharmaceutical multidose injector for calibrated injections from FDG or other radiopharmaceutical solutions. Features compact ergonomic design, autonomous battery power with 8-hour autonomy, and direct DICOM connectivity to hospital intranet.
- IBC Dose Calibrator (Comecer) Fully digital dose calibrator with IBC-LITE reading software. Supports unlimited user-defined isotopes, RS-232 interface, and simultaneous control of two ionization chambers.
- Gamma Probe Systems (Crystal Photonics) Complete line of gamma probes for surgical detection of radioactive-labeled tissues including Straight Probe (20-600 keV, 13mm tip), Angled Probe (30° design, 15mm tip), Laparoscopic Probe (0°, 45°, 90° angles), Wireless Gamma Probe (Bluetooth connectivity), and PET Probe (511 keV positron detection).
- Fume Hoods and Laminar Flow Cabinets (Comecer) Radiochemistry fume hoods (FHR series) for removing airborne radionuclides and laminar flow cabinets (FHB, BH series) for aseptic radiopharmaceutical preparation. Features AISI 304 stainless steel construction, HEPA/carbon filtration, and adjustable lead glass protection.
- Nuclear Medicine Safety and Laboratory Accessories Comprehensive range of nuclear medicine accessories including shielded containers, waste containers, mobile bed shields, pass-through boxes, refrigerated cells, and shielded safes for radiation safety.
Quantifiable outcome
- 30+ years of nuclear medicine expertise with nationwide Turkey coverage
- +1 more outcomes
Companies that use NEPHA
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
NEPHA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature8 records
NEPHA partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core.
- ATT Scintomics (SCINTOMICS Molecular, Applied Theranostics Technologies GmbH)coreSCINTOMICS Molecular, Applied Theranostics Technologies GmbH (SCI-att) is a leading and rapidly growing player in the radiopharmaceutical industry. Nepha established its collaboration with ATT-Scintomics in 2009, installing the first synthesis modules for labeling Ga-68 and Lu-177 with biological compounds. Nepha provides full automatic GRP module system services for synthesis of magistral products at various healthcare facilities.
- CuriumcoreCurium is the world's leading nuclear medicine company focused on developing, manufacturing, and supplying world-class radiopharmaceutical products. Nepha has represented Curium in Turkey since 1992, supplying Tc-99m generators, I-131 capsules, and cold kits (DTPA, HDP, MAG3, PYP) to healthcare institutions throughout Turkey with uninterrupted and timely delivery.
- Crystal Photonics GmbHcoreCrystal Photonics GmbH is a highly specialized manufacturer of detector systems and miniaturized nuclear radiation detectors for medical and industrial measurement technology, research, environmental protection, and defense. Nepha represents Crystal Photonics products in Turkey including gamma probes (Straight, Angled, Laparoscopic, Wireless), CrystalCam hand-gamma camera, and PET Probe.
- ComecercoreComecer is an Italy-based company established in the mid-1970s, developing and producing high-technology systems for aseptic treatment and preservation in the pharmaceutical and nuclear medicine industries. Nepha distributes the full Comecer product range in Turkey including hot cells (BBS, MIP, BBST series), fume hoods (FHR, FHB series), isolators, dispensing systems (IRIS, Clio, Argo, Theodorico, Timo 2), dose calibrators, and accessories.
- CyclomedicacoreCyclomedica is recognized worldwide as a nuclear medicine and molecular imaging provider, transforming lung diagnostic imaging and patient management with its groundbreaking Technegas® technology. Nepha distributes Cyclomedica's Technegas Plus system in Turkey, used for ventilation scintigraphy for pulmonary embolism, COPD, asthma, and lung infection diagnosis.
- Hermes Medical SolutionscoreHermes Medical Solutions is a pioneering Swedish organization continuously innovating to deliver faster and more personalized diagnosis and treatment in molecular imaging. Nepha distributes Hermia molecular imaging software in Turkey, a vendor-independent platform covering all clinical specialties with AI-powered automation and multimodal fusion capabilities.
- Sirtex MedicalcoreSirtex Medical is a global healthcare company with offices in the USA, Australia, Germany, and Singapore, working to improve outcomes for cancer patients. Its flagship product is SIR-Spheres® Y-90 resin microspheres, a radiation therapy for liver cancer. Nepha distributes Sirtex products in Turkey.
- iThemba LABScoreiThemba LABS produces the Ge-68/Ga-68 generator, an advanced radioisotope generator for nuclear medicine applications providing reliable and efficient Ga-68 production for PET imaging procedures, particularly in neuroendocrine tumor diagnosis. Nepha is the authorized Turkish distributor for iThemba Ge-68/Ga-68 generators.
Scale indicators6 records
Recent moves6 records
Expansion highlights4 records
NEPHA competitors and assessment
Company assessmentOthers
- Comecer: Italian manufacturer of hot cells, isolators, and dispensing systems for nuclear medicine; Nepha is its Turkish distributor. While a principal rather than a direct competitor, Comecer operates in the same equipment-adjacent niche and is closely comparable in product scope.
Broad incumbents
- Cardinal Health Radiopharmaceuticals: Operates the largest US commercial nuclear pharmacy network, distributing radiopharmaceuticals, generators, and related products to hospitals. Comparable distribution-led model in nuclear medicine but at significantly larger scale and broader portfolio.
- Lantheus Holdings: Radiopharmaceutical-focused manufacturer and distributor with products in SPECT (Tc-99m, Xenon) and emerging theranostics. Adjacent to Nepha's positioning as a radiopharma distributor with overlapping nuclear medicine hospital customer base.
- PETNET Solutions (Siemens Healthineers): Subsidiary of Siemens Healthineers operating the largest PET radiopharmaceutical manufacturing and distribution network in the US/UK. Comparable to Nepha in distributing PET tracers (FDG and others) to nuclear medicine departments, but as part of a much larger imaging conglomerate.
- IBA Molecular: Global producer and distributor of PET and SPECT radiopharmaceuticals serving hospitals and imaging centers. Comparable to Nepha as a radiopharmaceutical distributor with similar institutional customer base in nuclear medicine departments.
- Curium Pharma: World's largest nuclear medicine company; Nepha has been its Turkish representative since 1992. Comparable as a nuclear medicine distributor at global scale with overlapping product portfolio (Tc-99m generators, I-131, cold kits).
Direct peers
- Jubilant Radiopharma: Operates one of the largest radiopharmaceutical distribution networks in North America, supplying Tc-99m generators, I-131, and PET tracers to hospitals. Closely comparable to Nepha as a regional-to-multi-regional nuclear medicine distributor with similar product mix.
- SOFIE Therapeutics: US-based radiopharmaceutical manufacturer and distributor operating a PET tracer production and distribution network. Closely parallels Nepha's model of distributing molecular imaging agents and radiopharma products to healthcare institutions, though at much larger scale.
Regional players
- NTP Radioisotopes (NTPIR): South African state-affiliated producer and regional distributor of radiopharmaceuticals and radioisotopes across Africa. Most comparable international peer to Nepha as a regional nuclear medicine distributor serving a specific national market.
- ANSTO Health: Australian Nuclear Science and Technology Organisation's commercial arm, producing and distributing radiopharmaceuticals in Australia and the Asia-Pacific. Similar model of national-level nuclear medicine production and distribution with comparable regulatory profile.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
NEPHA social profiles
Digital presenceNEPHA compliance and trust
Trust signalCompliance7 records
NEPHA financial estimates
Financial estimateRevenue estimate
Valuation estimate
NEPHA leadership team
Management profileNumber of profiles
NEPHA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NEPHA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NEPHA
What does NEPHA do?
NEPHA Tıbbi Cihazlar is a Turkish medical device distributor and exclusive representative office serving the nuclear medicine sector since 1991. The company distributes radiopharmaceutical generators (Mo-99/Tc-99m, Ge-68/Ga-68), therapeutic products (I-131 capsules, SIR-Spheres Y-90 microspheres), nuclear medicine equipment (hot cells, isolators, gamma probes, dose calibrators, dispensing systems, synthesis modules), and Hermia molecular imaging software on behalf of eight world-leading international manufacturers. NEPHA serves 500+ healthcare customers across Turkey through its Ankara, Istanbul, and Izmir offices backed by a nationwide dealer network, providing both product supply and post-sale technical service support.
Is NEPHA a public or private company?
NEPHA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NEPHA founded?
NEPHA was founded in 1991. It employs 11 to 50 people.
Where is NEPHA based?
NEPHA is headquartered in Çankaya.
How does NEPHA make money?
One revenue line is on record: nuclear Medicine Medical Device Distribution.
Who are NEPHA's main competitors?
Comecer is listed as an others. Broad incumbents are Cardinal Health Radiopharmaceuticals, Lantheus Holdings, PETNET Solutions (Siemens Healthineers), IBA Molecular and Curium Pharma. Direct peers are Jubilant Radiopharma and SOFIE Therapeutics. Regional players are NTP Radioisotopes (NTPIR) and ANSTO Health.
Does NEPHA have an API?
No public API is recorded for NEPHA.
What industry is NEPHA in?
NEPHA's product category is Nuclear Medicine Medical Device Distribution. Its primary akta.pro industry code is HLAIAJAI, Radiopharmaceutical & Nuclear Medicine Distributors. Its NAICS code is 3254 and its SIC code is 5047.